Hai Yue
About Hai Yue
Hai Yue is the Director of Cell Therapy Product Analytical Strategy at Bristol Myers Squibb in Seattle, Washington, with extensive experience in analytical development and regulatory CMC submissions.
Company
Hai Yue currently holds the position of Director, Cell Therapy Product Analytical Strategy at Bristol Myers Squibb. The company is a renowned global biopharmaceutical corporation focused on the discovery, development, and delivery of innovative medicines for patients with serious diseases. Bristol Myers Squibb's commitment to cell therapy aligns with Yue's extensive background and expertise in the field.
Title
As the Director, Cell Therapy Product Analytical Strategy, Hai Yue focuses on the strategic analytics of cell therapy products. This role encompasses the oversight of analytical methods and strategies to ensure product quality and regulatory compliance. Yue’s position is integral to the development and lifecycle management of cell therapy products at Bristol Myers Squibb.
Career at Bristol Myers Squibb
Hai Yue joined Bristol Myers Squibb in 2019 and has since advanced through several critical roles within the company. Initially serving as Associate Director/Principal Scientist, Cell Therapy Analytical Development, Yue was promoted to Director, Cell Therapy Analytical Development from 2021 to 2022. Currently, Yue is the Director, Cell Therapy Product Analytical Strategy. Throughout these positions, Yue has led efforts in analytical development and strategy for cell therapy products, playing a pivotal role in regulatory submissions and product development.
Previous Positions
Before joining Bristol Myers Squibb, Hai Yue gained substantial experience in the biopharmaceutical field. From 2017 to 2019, Yue was a Senior Scientist in Cell Therapy Analytical Development at Juno Therapeutics, Inc. Prior to that, Yue worked for four years at Amgen as a Scientist in Analytical/Attribute Sciences. Yue's career began with a 6-month stint as a Ph.D. Intern in Analytical Development at GSK in 2012. Each of these roles contributed to Yue's expertise in analytical sciences and cell therapy.
Education and Expertise
Hai Yue earned a Ph.D. in Biochemistry from Washington University in St. Louis, where Yue studied from 2007 to 2013. Yue's academic background in biochemistry laid a strong foundation for an extensive career in analytical sciences and cell therapy. Yue has notable experience in supporting regulatory Chemistry, Manufacturing, and Controls (CMC) submissions to global health authorities and has been deeply involved in technological innovations in analytical and process methods.